John Cavan Insider Profile
4 Followers
John Cavan, CFO at Hepion Pharmaceuticals, holds 14.80K shares in Hepion Pharmaceuticals (Ticker: HEPA), holds 0.00 shares in Aegerion (Ticker: AEGR). Most recently, John Cavan Bought ― shares of Hepion Pharmaceuticals on Feb 18, 2021 for an estimated value of $20.00K.
John Cavan's Trading History
| HEPAHepion Pharmaceuticals | Feb 18, 2021 | CFO | Informative Buy | 20.00K | $1.69K | |
| AEGRAegerion | ― | ― | ― | $0.00 |
You May Also Like
John Cavan insider profile FAQ
What is the percentage of profitable transactions made by John Cavan?
The percentage of profitable transactions made by John Cavan is 0%.
What is the average return per transaction made by John Cavan?
The average return per transaction made by John Cavan is -49.90%.
What stocks does John Cavan hold?
John Cavan holds: HEPA, AEGR stocks.
What was John Cavan’s latest transaction?
John Cavan’s latest transaction was an Informative Buy of $20.00K.
What was John Cavan's most profitable transaction?
John Cavan’s most profitable transaction was an Informative Buy of HEPA stock on November 30, 2020. The return on the trade was -25.70%.
What is John Cavan's role in Hepion Pharmaceuticals?
John Cavan's role in Hepion Pharmaceuticals is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
